Skip to main content
SI

SignalRx Pharmaceuticals

Omaha, United States
Last funding
$250K
UndisclosedApr 2023

SignalRx is a clinical-stage company that focuses on the development of effective anticancer treatments inducing the immune system.

About SignalRx Pharmaceuticals

How much funding has SignalRx Pharmaceuticals raised?

SignalRx Pharmaceuticals has raised $250K in total funding. The most recent round was Undisclosed. The last funding was announced in April 2023.

Where is SignalRx Pharmaceuticals headquartered?

SignalRx Pharmaceuticals is headquartered in Omaha, United States.

What does SignalRx Pharmaceuticals do?

SignalRx is a clinical-stage company that focuses on the development of effective anticancer treatments inducing the immune system.

What stage is SignalRx Pharmaceuticals at?

SignalRx Pharmaceuticals is at the Undisclosed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"SignalRx Pharmaceuticals — Funding & Investors." VCBacked, April 26, 2023, https://www.vcbacked.co/company/signalrx-pharmaceuticals. Accessed November 13, 2026.
APA
VCBacked. (2023). SignalRx Pharmaceuticals — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/signalrx-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=SignalRx Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/signalrx-pharmaceuticals |website=VCBacked |access-date=November 13, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at SignalRx Pharmaceuticals? Request a listing update

Founder contacts
m***@signalrx.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →